Valuation: Hikma Pharmaceuticals PLC

Market Cap 4.76B 4.12B 3.85B 3.53B 6.64B 453B 6.74B 45.12B 17.71B 227B 17.88B 17.49B 751B P/E 2026 *
12.2x
P/E 2027 * 11.4x
Enterprise Value 6.25B 5.41B 5.05B 4.63B 8.71B 595B 8.85B 59.24B 23.25B 298B 23.47B 22.96B 986B EV / Sales 2026 *
1.8x
EV / Sales 2027 * 1.68x
Free-Float
63.4%
Yield 2026 *
3.85%
Yield 2027 * 4.04%
1 day-1.29%
1 week+5.80%
Current month+5.80%
1 month+0.96%
3 months+18.89%
6 months+8.90%
Current year+8.19%
1 week 1,563
Extreme 1563
1,755
1 month 1,483
Extreme 1483
1,755
Current year 1,187
Extreme 1187
1,762
1 year 1,187
Extreme 1187
1,865
3 years 1,187
Extreme 1187
2,360
5 years 1,174.5
Extreme 1174.5
2,625
10 years 814.2
Extreme 814.2
2,768
Manager TitleAgeSince
Chief Executive Officer 69 2025-11-30
Director of Finance/CFO - 2026-02-25
Chief Tech/Sci/R&D Officer 64 2026-02-25
Director TitleAgeSince
Director/Board Member 69 2005-10-13
Director/Board Member 54 2025-12-14
Chairman 69 2014-05-14
Date Insider Type Main position Quantity % Market Cap.
12/19/25 Buy

Director

100,000 0.0451%
11/11/25 Buy

Chief Executive Officer

70,000 0.0315%
11/11/25 Buy

Chief Executive Officer

100,000 0.0451%
Change 5-day change 1-year change 3-year change Capi.($)
-1.29%+5.80%-4.17%-21.96% 4.76B
-0.52%+3.21%+85.02%+161.12% 1,057B
+0.88%+1.13%+51.13%+49.76% 625B
+0.89%-1.95%+23.73%+63.67% 435B
+0.71%+3.87%+47.45%+38.68% 363B
+0.64%-0.49%+35.39%+40.21% 296B
+0.39%-5.83%+8.64%+9.28% 249B
+1.51%+6.69%+44.34%+62.47% 222B
+3.92%-0.46%-1.21%-44.09% 209B
+1.80%+2.30%+20.79%+65.13% 165B
Average +1.05%+1.36%+31.11%+42.43% 362.55B
Weighted average by Cap. +1.12%+1.22%+48.27%+75.21%

Financials

2026 *2027 *
Net sales 3.46B 3B 2.8B 2.57B 4.83B 330B 4.9B 32.83B 12.89B 165B 13.01B 12.72B 546B 3.61B 3.12B 2.91B 2.67B 5.03B 343B 5.11B 34.2B 13.42B 172B 13.55B 13.25B 569B
Net income 410M 355M 331M 304M 572M 39.05B 581M 3.89B 1.53B 19.57B 1.54B 1.51B 64.7B 428M 370M 346M 317M 597M 40.74B 606M 4.06B 1.59B 20.42B 1.61B 1.57B 67.5B
Net Debt 1.49B 1.29B 1.2B 1.1B 2.08B 142B 2.11B 14.12B 5.54B 71.09B 5.6B 5.47B 235B 1.31B 1.14B 1.06B 973M 1.83B 125B 1.86B 12.44B 4.88B 62.61B 4.93B 4.82B 207B
Logo Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company engaged in the development, manufacturing and marketing of a broad range of generic, branded and specialty pharmaceutical products. Its pharmaceutical operations are conducted through three business segments: Injectables, Branded and Hikma Rx. It supplies hospitals across North America, Europe and the Middle East and North Africa (MENA) region with generic injectable and specialty medicines, supported by its growing global manufacturing network. It supplies branded generic and in-licensed products from its local manufacturing facilities to retail and hospital customers across the MENA region. Through Hikma Rx, it supplies oral, respiratory and other generic and specialty products to the North American market. Its manufacturing facilities in the United States (US) supply products across a broad range of therapeutic areas, including respiratory, oncology and pain management, serving customers in both the US and Canada.
Employees
9,400
Date Price Change Volume
26-08-07 GBX 1,677.00 -1.29% 910,854
26-08-06 GBX 1,699.00 +8.15% 2,631,565
26-08-05 GBX 1,571.00 -0.63% 2,232,928
26-08-04 GBX 1,581.00 +0.51% 510,213
26-08-03 GBX 1,573.00 -0.76% 602,787
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
22.63USD
Average target price
25.01USD
Spread / Average Target
+10.51%

Quarterly revenue - Rate of surprise